UnitedHealth Group (UNH) Stock Forecast & Price Target

$412.57 +6.00 (+1.47%)

Closing price 06/9/2026 03:59 PM Eastern

Extended Trading

$410.88 -1.68 (-0.41%)

As of 05:37 AM Eastern

Compare

UnitedHealth Group - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 27 Analyst Ratings

Sell
1

Hold
5

Buy
21

Based on 27 Wall Street analysts who have issued ratings for UnitedHealth Group in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 27 analysts, 1 has given a sell rating, 5 have given a hold rating, 20 have given a buy rating, and 1 has given a strong buy rating for UNH.

Consensus Price Target

$407.17
-1.31% Downside

According to the 27 analysts' twelve-month price targets for UnitedHealth Group, the average price target is $407.17. The highest price target for UNH is $492.00, while the lowest price target for UNH is $287.00. The average price target represents a forecasted downside of -1.31% from the current price of $412.57.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for UNH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for UnitedHealth Group and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

UNH Analyst Ratings Over Time

Type	Current Forecast 6/10/25 to 6/10/26	1 Month Ago 5/11/25 to 5/11/26	3 Months Ago 3/12/25 to 3/12/26	1 Year Ago 6/10/24 to 6/10/25
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	20 Buy rating(s)	20 Buy rating(s)	17 Buy rating(s)	17 Buy rating(s)
Hold	5 Hold rating(s)	7 Hold rating(s)	8 Hold rating(s)	6 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	2 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$407.17	$378.88	$372.13	$428.43
Forecasted Upside	-1.31% Downside	-1.44% Downside	34.20% Upside	40.98% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

UNH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

UNH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

UnitedHealth Group Stock vs. The Competition

Type	UnitedHealth Group	Medical Companies	Broader Market
Consensus Rating Score	2.78	2.30	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	-1.31% Downside	760.74% Upside	14.83% Upside
News Sentiment Rating	Positive News See Recent UNH News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
6/8/2026	Mizuho 4 of 5 stars	Ann Hynes 2 of 5 stars	Boost Target	Outperform	$440.00 ➝ $460.00	+13.92%
6/8/2026	JPMorgan Chase & Co. 3 of 5 stars	Lisa Gill 3 of 5 stars	Boost Target	Overweight	$420.00 ➝ $466.00	+15.49%
6/4/2026	Morgan Stanley 3 of 5 stars	Erin Wright 4 of 5 stars	Boost Target	Overweight	$395.00 ➝ $453.00	+14.23%
6/4/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Fischbeck Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$420.00 ➝ $450.00	+19.03%
6/1/2026	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David MacDonald Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$395.00 ➝ $440.00	+15.12%
5/27/2026	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$492.00	+30.34%
5/27/2026	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lance Wilkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$444.00 ➝ $492.00	+30.34%
5/26/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Mok Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$373.00 ➝ $429.00	+13.12%
5/22/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	A.J. Rice Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$410.00 ➝ $460.00	+18.10%
5/7/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Sell (D+) ➝ Hold (C-)
Uncle Sam now owns 9.9% of Intel (Ad) On August 22, 2025, the U.S. government became one of Intel's largest shareholders - converting CHIPS Act grants into a 9.9% equity stake worth 8.9 billion dollars at 20.47 per share. Weeks earlier, the DoD took a 15% stake in rare-earth miner MP Materials, and the DOE followed with a 5% stake in Lithium Americas alongside a 2.23 billion dollar loan. Federal equity ownership in semiconductors, rare earths, and lithium - at this scale - hasn't happened since World War II. Porter Stansberry says the rules of investing are changing, and the stocks positioned to win this realignment aren't the ones the financial press is covering. Watch the full documentary to see which stocks to buy and sell now
4/27/2026	Erste Group Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Hold ➝ Buy
4/23/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Langston Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Hold	$311.00 ➝ $337.00	-4.67%
4/22/2026	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Whit Mayo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$345.00 ➝ $400.00	+12.34%
4/22/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Hendrix Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$361.00 ➝ $400.00	+12.34%
4/22/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Baxter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$370.00 ➝ $397.00	+11.49%
4/22/2026	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Wiederhorn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$385.00 ➝ $405.00	+13.95%
4/22/2026	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Ha Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Underperform	$278.00 ➝ $287.00	-18.98%
4/22/2026	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Toung Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Hold ➝ Buy	$400.00	+15.52%
4/20/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Windley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$340.00 ➝ $373.00	+15.26%
4/7/2026	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Reduce ➝ Hold	$300.00	+6.59%
4/1/2026	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Ransom Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Market Perform ➝ Outperform	$330.00	+22.11%
1/28/2026	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Gillmor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight
1/27/2026	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jessica Tassan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight
1/6/2026	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Strong-Buy
10/29/2025	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Buy ➝ Hold	$333.00	-9.69%
10/14/2025	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Fidel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Buy	$406.00	+13.15%
10/6/2025	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Strong Sell ➝ Hold
8/26/2025	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sarah James Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight	$440.00	+44.13%
5/20/2025	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Justin Lake Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$501.00 ➝ $390.00	+21.90%
5/19/2025	TD Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Langston Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$520.00 ➝ $308.00	-1.39%
12/5/2024	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Overweight	$605.00 ➝ $675.00	+10.54%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 05:38 AM ET.

UNH Forecast - Frequently Asked Questions

According to the research reports of 27 Wall Street equities research analysts, the average twelve-month stock price forecast for UnitedHealth Group is $407.17, with a high forecast of $492.00 and a low forecast of $287.00.

27 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for UnitedHealth Group in the last twelve months. There is currently 1 sell rating, 5 hold ratings, 20 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" UNH shares.

According to analysts, UnitedHealth Group's stock has a predicted downside of -1.31% based on their 12-month stock forecasts.

Over the previous 90 days, UnitedHealth Group's stock had 6 upgrades by analysts.

UnitedHealth Group has been rated by research analysts at Argus, Bank of America, Barclays, Erste Group Bank, HC Wainwright, HSBC, Jefferies Financial Group, JPMorgan Chase & Co., Leerink Partners, Mizuho, Morgan Stanley, Oppenheimer, Raymond James Financial, Robert W. Baird, Royal Bank Of Canada, Sanford C. Bernstein, TD Cowen, Truist Financial, UBS Group, Weiss Ratings, and Wells Fargo & Company in the past 90 days.

Analysts like UnitedHealth Group more than other "medical" companies. The consensus rating for UnitedHealth Group is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how UNH compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With UnitedHealth Group Recommendations

This page (NYSE:UNH) was last updated on 6/10/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

UnitedHealth Group (UNH) Stock Forecast & Price Target

UnitedHealth Group - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

UNH Analyst Ratings Over Time

UNH Analyst Recommendations By Month

UNH Price Targets by Month

UnitedHealth Group Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

UNH Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With UnitedHealth Group Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

UnitedHealth Group (UNH) Stock Forecast & Price Target

UnitedHealth Group - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

UNH Analyst Ratings Over Time

UNH Analyst Recommendations By Month

UNH Price Targets by Month

UnitedHealth Group Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

UNH Forecast - Frequently Asked Questions

What is UnitedHealth Group's forecast for 2026?

Should I buy or sell UnitedHealth Group stock right now?

Does UnitedHealth Group's stock price have much downside?

Has UnitedHealth Group been upgraded by Wall Street analysts recently?

What analysts cover UnitedHealth Group?

Do Wall Street analysts like UnitedHealth Group more than its competitors?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With UnitedHealth Group Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools